US Imposes New Tariffs, Economic Data Mixed, and Diplomatic Tensions Rise
Key Takeaways The United States has announced a significant shift in trade policy, publishing detailed tariff codes under Section 232 […]
Breaking News
Trump and Putin Commence High-Stakes Alaska Summit Amid Ukraine War, Sanctions Threat
Key Takeaways U.S. President Donald Trump and Russian President Vladimir Putin have commenced their highly anticipated summit in Anchorage, Alaska,
Pharma Giants Shed $250 Billion Amid Weight-Loss Concerns and Trump Threats; High-Stakes Trump-Putin Meeting Expands
Key Takeaways Novo Nordisk (NVO) and Eli Lilly (LLY) collectively saw their market capitalization plummet by $250 billion on Friday,
Market Movers: Pharma Giants Battle, Geopolitical Tensions Rise, and Energy Sector Expands
Key Takeaways Eli Lilly (LLY) has bolstered its position in the competitive obesity and cardiometabolic drug market, signing a US$1.3
High-Stakes Summit Underway as Trump Expresses Optimism, Market Confidence
Key Takeaways President Trump has expressed optimism regarding his meeting with Russian President Vladimir Putin in Alaska, stating that he
Microsoft Forges Prediction Market Alliance; Oil Prices Ease on Peace Hopes
Key Takeaways Microsoft's (MSFT) gaming division, including Activision and its flagship Call of Duty franchise, has reportedly partnered with prediction
Energy Markets Stable as Rig Count Holds; WEF Clears Schwab
Key Takeaways The U.S. total rig count remained steady at 539, with oil rigs seeing a slight increase while gas
Federal Reserve Shifts Crypto Oversight, ChatGPT Mobile Revenue Hits $2 Billion, and Trump Issues Warning Ahead of Putin Summit
Key Takeaways The Federal Reserve is ending its specialized "novel activities supervision program," integrating oversight of banks' crypto and fintech
Market Volatility Surges as CoreWeave Trades Stir Speculation, Apple Faces Tariff Hit, and Geopolitical Tensions Mount
Key Takeaways CoreWeave shares experienced multiple large block trades, with 11 million shares placed by Goldman Sachs, JPMorgan, and Morgan
Market Movers: Pfizer’s Sickle Cell Drug Fails Phase 3, Lukoil Refinery Halts, BP Gains on Takeover Buzz
Key Takeaways Pfizer's (PFE) experimental sickle cell disease drug, Inclacumab (also known as Thrive-131), failed to achieve its primary endpoint